Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 30,531,795 | 120,531,292 | - | 11.4 | 348,978,417 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 30,531,795 | 120,531,292 | - | 11.4 | 348,978,417 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 10,125,546 | 39,972,917 | - | 11.4 | 115,734,991 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 10,125,546 | 39,972,917 | - | 11.4 | 115,734,991 | Common Stock |
| Best Buy | Richard M. Schulze | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 85.84 per share. | 30 May 2024 | 983,746 | 15,890,103 (6%) | 0% | 85.8 | 84,440,822 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 965,651 | 3,812,112 | - | 11.4 | 11,037,391 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 965,651 | 3,812,112 | - | 11.4 | 11,037,391 | Common Stock |
| Best Buy | Richard M. Schulze | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 80.21 per share. | 30 May 2024 | 724,974 | 17,890,103 (6%) | 0% | 80.2 | 58,153,282 | Common Stock |
| Best Buy | Richard M. Schulze | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 80.26 per share. | 30 May 2024 | 651,685 | 16,890,103 (6%) | 0% | 80.3 | 52,304,955 | Common Stock |
| BARK Inc (Class A) | Michael Scott Black | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 500,000 | 500,000 | - | 0 | Common Stock | |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 30 May 2024 | 406,885 | 406,885 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 30 May 2024 | 406,885 | 49,694,720 | - | - | Class B Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 30 May 2024 | 406,885 | 0 | - | 21.3 | 8,657,536 | Class A Common Stock |
| Alphabet (Class A) | Sergey Brin | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 384,600 | 363,945,408 (106%) | 0% | 0 | Class C Capital Stock | |
| Alphabet (Class A) | Sergey Brin | Director, Ten Percent Owner | 30 May 2024 | 384,600 | 384,600 (0%) | 0% | 0 | Class A Common Stock | ||
| Alphabet (Class A) | Sergey Brin | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 384,600 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Alphabet (Class A) | Sergey Brin | Director, Ten Percent Owner | 30 May 2024 | 384,600 | 362,744,028 | - | - | Class B Common Stock | ||
| Best Buy | Richard M. Schulze | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 81.38 per share. | 30 May 2024 | 348,315 | 17,541,788 (6%) | 0% | 81.4 | 28,346,502 | Common Stock |
| Best Buy | Richard M. Schulze | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 80.21 per share. | 30 May 2024 | 274,228 | 8,850 (0%) | 0% | 80.2 | 21,997,007 | Common Stock |
| Installed Building Products Inc | Jeffrey W. Edwards | Director, President, CEO and Chairman, Ten Percent Owner | 30 May 2024 | 250,000 | 250,000 | - | - | Forward sale contract (potential obligation to sell) | ||
| BARK Inc (Class A) | Michael Scott Black | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Zurn Elkay Water Soln Corp | Timothy J. Jahnke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 200,000 | 393,485 (0%) | 0% | 0 | Common Stock | |
| Laureate Education Inc | Marcelo Barbalho Cardoso | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 190,961 | 373,009 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc | Kelly D. Deck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| TTEC Holdings Inc | Michelle R. Swanback | PRESIDENT, CEO, TTEC ENGAGE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 167,560 | 167,560 | - | - | Restricted Stock Unit | |
| Designer Brands Inc (Class A) | Douglas M. Howe | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 140,507 | 235,245 (0%) | 0% | 0 | Class A Common Shares | |
| Designer Brands Inc (Class A) | Douglas M. Howe | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 135,222 | 135,222 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 129,667 | 834,409 | - | - | Stock Option (right to buy) | |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.01 per share. | 30 May 2024 | 129,667 | 286,522 | - | 5.0 | 649,632 | Class A Common Stock |
| Laureate Education Inc | Richard M. Buskirk | SVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 127,307 | 264,091 | - | 0 | Common Stock | |
| Analog Devices | Gregory M. Bryant | EVP & Pres. Global Bus. Units | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 120,069 | 137,102 (0%) | 0% | 0 | Comm Stock - $.16-2/3 value | |
| Analog Devices | Gregory M. Bryant | EVP & Pres. Global Bus. Units | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 120,069 | 120,069 | - | - | Performance-Based Restricted Stock Unit | |
| Mawson infra Grp Inc | Ryan Costello | Director | 30 May 2024 | 118,395 | 0 | - | - | Restricted Stock Units | ||
| Mawson infra Grp Inc | Ryan Costello | Director | 30 May 2024 | 118,395 | 118,395 | - | - | Common Stock | ||
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | 30 May 2024 | 116,669 | 116,669 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | 30 May 2024 | 116,669 | 58,012,073 | - | - | Class B Common Stock | ||
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | Sale of securities on an exchange or to another person at price $ 22.02 per share. | 30 May 2024 | 116,669 | 0 | - | 22.0 | 2,569,611 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 20.47 per share. | 30 May 2024 | 114,460 | 172,062 | - | 20.5 | 2,343,271 | Class A Common Stock |
| Jefferies Fin Grp Inc | Richard B. Handler | Director, CEO | Grant, award, or other acquisition of securities at price $ 45.79 per share. | 30 May 2024 | 82,404 | 15,396,554 (5%) | 0% | 45.8 | 3,773,279 | Common Stock |
| Humacyte Inc | Heather Prichard | Chief Operating Officer | 30 May 2024 | 78,779 | 81,404 | - | 2.6 | 201,674 | Common Stock | |
| Humacyte Inc | Heather Prichard | Chief Operating Officer | 30 May 2024 | 78,779 | 2,625 | - | 8.4 | 658,592 | Common Stock | |
| Humacyte Inc | Heather Prichard | Chief Operating Officer | 30 May 2024 | 78,779 | 0 | - | - | Stock Options (right to buy) | ||
| Apple | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 191.58 per share. | 30 May 2024 | 75,000 | 4,359,576 (0%) | 0% | 191.6 | 14,368,500 | Common Stock |
| Advanced Drainage Systems Inc | Scott A. Cottrill | EVP, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 173.11 per share. | 30 May 2024 | 73,207 | 91,442 (0%) | 0% | 173.1 | 12,672,630 | Common Stock |
| Entravision Comm Corp (Class A) | Gilbert R. Vasquez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 71,100 | 879,376 (1%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Paul A. Zevnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 71,100 | 255,955 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Lara Sweet | Director | 30 May 2024 | 71,100 | 98,367 (0%) | 0% | 0 | Class A common stock | ||
| Entravision Comm Corp (Class A) | Martha Elena Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 71,100 | 261,158 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Fehmi Zeko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 71,100 | 219,168 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Thomas Strickler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 71,100 | 114,362 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Brad Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 71,100 | 104,362 (0%) | 0% | 0 | Class A common stock | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | William F. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Uma Sinha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Jose Ignacio Jimenez Santos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Humacyte Inc | Heather Prichard | Chief Operating Officer | 30 May 2024 | 61,941 | 2,625 | - | 7.7 | 477,565 | Common Stock | |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 82.00 per share. | 30 May 2024 | 59,000 | 197,382 (0%) | 0% | 82 | 4,838,000 | Ordinary Shares |
| Huntington Bancshares | Helga Houston | Senior Exec. V. P. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.89 per share. | 30 May 2024 | 58,365 | 656,182 (0%) | 0% | 10.9 | 635,595 | Common Stock |
| Huntington Bancshares | Helga Houston | Senior Exec. V. P. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 58,365 | 0 | - | - | Employee/Director Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Kevin M. Charlton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 54,195 | 54,195 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 54,195 | 54,195 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Merline Saintil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 54,195 | 54,195 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Neil Glat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 54,195 | 54,195 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | David Mounts Gonzales | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 54,195 | 54,195 | - | - | Restricted Stock Units | |
| Analog Devices | Gregory M. Bryant | EVP & Pres. Global Bus. Units | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.00 per share. | 30 May 2024 | 50,248 | 86,853 (0%) | 0% | 230.0 | 11,557,241 | Comm Stock - $.16-2/3 value |
| Atyr Pharma Inc | Timothy P. Coughlin | Director | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 30 May 2024 | 50,000 | 56,000 (0%) | 0% | 1.8 | 87,500 | Common Stock |
| Vital Farms Inc | Matthew O’Hayer | Director, EXECUTIVE CHAIRPERSON, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 41.72 per share. | 30 May 2024 | 50,000 | 7,364,777 | - | 41.7 | 2,086,000 | Common Stock |
| LoanDepot Inc (Class A) | Frank D. Martell | Director, CEO and President | 30 May 2024 | 50,000 | 361,846 (0%) | 0% | 1.8 | 90,000 | Class A Common Stock | |
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 30 May 2024 | 50,000 | 2,956,605 (4%) | 0% | 1.8 | 90,295 | Class A Common Stock |
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 30 May 2024 | 50,000 | 2,906,605 (4%) | 0% | 1.8 | 90,530 | Class A Common Stock |
| Designer Brands Inc (Class A) | Douglas M. Howe | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 30 May 2024 | 48,721 | 186,524 (0%) | 0% | 9.3 | 454,567 | Class A Common Shares |
| Intel | Patrick P. Gelsinger | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 48,216 | 96,447 | - | - | Restricted Stock Units | |
| Intel | Patrick P. Gelsinger | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 48,216 | 58,905 (0%) | 0% | - | Common Stock | |
| Humacyte Inc | Heather Prichard | Chief Operating Officer | 30 May 2024 | 48,166 | 2,625 | - | 8.3 | 400,741 | Common Stock | |
| Humacyte Inc | Heather Prichard | Chief Operating Officer | 30 May 2024 | 48,166 | 50,791 | - | 3.1 | 147,870 | Common Stock | |
| Humacyte Inc | Heather Prichard | Chief Operating Officer | 30 May 2024 | 48,166 | 87,834 | - | - | Stock Options (right to buy) | ||
| Extreme Networks Inc | Kevin R. Rhodes | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 47,370 | 75,221 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Kevin R. Rhodes | EVP Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 47,370 | 94,880 | - | - | Restricted Stock Units | |
| Intel | Michelle Johnston Holthaus | EVP & GM, CCG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 46,198 | 92,410 | - | - | Restricted Stock Units | |
| Intel | Michelle Johnston Holthaus | EVP & GM, CCG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 46,198 | 306,590 (0%) | 0% | - | Common Stock | |
| Advanced Drainage Systems Inc | Scott A. Cottrill | EVP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.20 per share. | 30 May 2024 | 43,809 | 164,649 (0%) | 0% | 24.2 | 1,060,178 | Common Stock |
| Advanced Drainage Systems Inc | Scott A. Cottrill | EVP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 43,809 | 0 | - | - | Option to Purchase Common Stock | |
| Huntington Bancshares | Helga Houston | Senior Exec. V. P. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.64 per share. | 30 May 2024 | 43,764 | 597,817 (0%) | 0% | 13.6 | 596,941 | Common Stock |
| Bandwidth Inc (Class A) | Daryl E. Raiford | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 42,409 | 81,486 (0%) | 0% | 0 | Class A Common Stock | |
| Bandwidth Inc (Class A) | Daryl E. Raiford | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 42,409 | 84,817 | - | - | Restricted Stock Units | |
| TTEC Holdings Inc | David J. Seybold | CEO, TTEC DIGITAL | 30 May 2024 | 41,890 | 41,890 | - | - | Restricted Stock Units | ||
| Intel | Christoph Schell | EVP; Chief Cml Ofcr; SMG | 30 May 2024 | 41,712 | 81,840 (0%) | 0% | - | Common Stock | ||
| Intel | Christoph Schell | EVP; Chief Cml Ofcr; SMG | 30 May 2024 | 41,712 | 83,439 | - | - | Restricted Stock Units | ||
| Coupang Inc (Class A) | Hanseung Kang | Rep Director, Business Mngmt | 30 May 2024 | 40,000 | 544,478 | - | 23 | 920,000 | Class A Common Stock | |
| Celldex Therapeutics Inc | Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 30 May 2024 | 38,719 | 7,094 (0%) | 0% | 34.1 | 1,319,156 | Common Stock |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Sale of securities on an exchange or to another person at price $ 33.64 per share. | 30 May 2024 | 38,597 | 9,074 (0%) | 0% | 33.6 | 1,298,384 | Common Stock |
| Paycom | Randall Peck | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 37,500 | 40,613 (0%) | 0% | 0 | Common Stock | |
| Intel | David A. Zinsner | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 37,003 | 74,018 | - | - | Restricted Stock Units | |
| Intel | David A. Zinsner | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 37,003 | 167,628 (0%) | 0% | - | Common Stock | |
| Celldex Therapeutics Inc | Sam Martin | SVP AND CFO | Sale of securities on an exchange or to another person at price $ 34.05 per share. | 30 May 2024 | 35,000 | 25,128 (0%) | 0% | 34.1 | 1,191,775 | Common Stock |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 34,445 | 0 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 30 May 2024 | 34,445 | 39,171 (0%) | 0% | 2.8 | 95,757 | Common Stock |
| Sportsman`s Warehouse Holdings Inc | Richard D. Mcbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 32,577 | 185,608 (0%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 31,250 | 194,098 (1%) | 0% | - | Common Stock | |
| Hovnanian Enterprises Inc (Class A) | Ara K. Hovnanian | Director, Chairman of Bd., Pres. & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 31,202 | 62,404 | - | - | Performance Share Units (2023) | |
| Booz Allen Hamilton Holding Corp (Class A) | Susan L. Penfield | EVP & Chief Technology Officer | 30 May 2024 | 30,161 | 52,310 (0%) | 0% | 36.0 | 1,084,288 | Class A Common Stock | |
| Booz Allen Hamilton Holding Corp (Class A) | Susan L. Penfield | EVP & Chief Technology Officer | 30 May 2024 | 30,161 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Inhibrx Biosciences Inc | Kimberly J. Manhard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Inhibrx Biosciences Inc | Kristiina Vuori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Advanced Drainage Systems Inc | Scott A. Cottrill | EVP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.20 per share. | 30 May 2024 | 29,398 | 120,840 (0%) | 0% | 24.2 | 711,432 | Common Stock |
| Advanced Drainage Systems Inc | Scott A. Cottrill | EVP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 29,398 | 0 | - | - | Option to Purchase Common Stock | |
| Celldex Therapeutics Inc | Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 30 May 2024 | 29,068 | 41,162 (0%) | 0% | 2.8 | 80,809 | Common Stock |
| Celldex Therapeutics Inc | Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 29,068 | 12,732 | - | - | Incentive Stock Option (Right to Buy) | |
| Arteris Inc | Antonio J. Viana | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 29,027 | 230,558 | - | 0 | Common Stock | |
| Arteris Inc | Antonio J. Viana | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 29,027 | 19,288 | - | 0 | Common Stock | |
| Arteris Inc | Antonio J. Viana | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 29,027 | 19,288 | - | 0 | Common Stock | |
| Arteris Inc | Antonio J. Viana | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 29,027 | 230,558 | - | 0 | Common Stock | |
| Sportsman`s Warehouse Holdings Inc | Steven R. Becker | Director | 30 May 2024 | 28,328 | 141,131 (0%) | 0% | 0 | Common Stock | ||
| Sportsman`s Warehouse Holdings Inc | Martha Helena Bejar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 28,328 | 81,997 (0%) | 0% | 0 | Common Stock | |
| Sportsman`s Warehouse Holdings Inc | Nancy A. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 28,328 | 52,965 (0%) | 0% | 0 | Common Stock | |
| Motorola | Gregory Q. Brown | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 28,325 | 0 (0%) | 0% | 0 | Motorola Solutions, Inc. - Common Stock | |
| TTEC Holdings Inc | Margaret B. McLean | GC & CRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 28,150 | 28,150 | - | - | Restricted Stock Units | |
| Altisource Portfolio Soln S.A. | Roland Mueller-Ineichen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 28,037 | 109,331 (0%) | 0% | 0 | Common Stock | |
| Altisource Portfolio Soln S.A. | Joseph L. Morettini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 28,037 | 86,098 (0%) | 0% | 0 | Common Stock | |
| Altisource Portfolio Soln S.A. | John G. Aldridge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 28,037 | 88,642 (0%) | 0% | 0 | Common Stock | |
| Biohaven Ltd | John W. Childs | Director | Purchase of securities on an exchange or from another person at price $ 35.58 per share. | 30 May 2024 | 28,000 | 2,311,341 | - | 35.6 | 996,240 | Common Shares |
| Arteris Inc | Antonio J. Viana | Director | Sale of securities on an exchange or to another person at price $ 7.85 per share. | 30 May 2024 | 26,919 | 203,639 | - | 7.9 | 211,435 | Common Stock |
| Arteris Inc | Antonio J. Viana | Director | Sale of securities on an exchange or to another person at price $ 7.85 per share. | 30 May 2024 | 26,191 | 204,367 | - | 7.9 | 205,717 | Common Stock |
| Jefferies Fin Grp Inc | Brian P. Friedman | Director, President | Grant, award, or other acquisition of securities at price $ 45.79 per share. | 30 May 2024 | 26,115 | 2,452,069 (0%) | 0% | 45.8 | 1,195,806 | Common Stock |
| Verizon Communincations | Craig L. Silliman | EVP&Pres.-VZ Global Services | 30 May 2024 | 26,068 | 237,684 | - | - | Phantom Stock (unitized) | ||
| CRISPR Therapeutics AG | Christian Rommel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Kevin M. Charlton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 277,765 | - | 0 | Class A Common Stock | |
| Evolv Tech Holdings Inc (Class A) | Kevin M. Charlton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 0 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 0 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 121,123 | - | 0 | Class A Common Stock | |
| Evolv Tech Holdings Inc (Class A) | Merline Saintil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 0 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Merline Saintil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 88,840 | - | 0 | Class A Common Stock | |
| Evolv Tech Holdings Inc (Class A) | Neil Glat | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 0 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Neil Glat | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 154,022 | - | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Peter J. Kight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,773 | 1,620,070 (4%) | 0% | 0 | Class A Common Stock | |
| Skyworks | Robert A. Schriesheim | Director | Sale of securities on an exchange or to another person at price $ 90.27 per share. | 30 May 2024 | 25,433 | 60,881 (0%) | 0% | 90.3 | 2,295,837 | Common Stock |
| Kontoor Brands Inc | Scott H. Baxter | Director, Chair, President and CEO | Sale of securities on an exchange or to another person at price $ 72.05 per share. | 30 May 2024 | 25,332 | 318,188 (0%) | 0% | 72.0 | 1,825,095 | Common Stock |
| Kontoor Brands Inc | Scott H. Baxter | Director, Chair, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.27 per share. | 30 May 2024 | 25,332 | 343,520 (0%) | 0% | 25.3 | 640,099 | Common Stock |
| Kontoor Brands Inc | Scott H. Baxter | Director, Chair, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,332 | 0 | - | - | Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc | Sam Martin | SVP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 30 May 2024 | 25,000 | 60,128 (0%) | 0% | 10.4 | 259,500 | Common Stock |
| Celldex Therapeutics Inc | Sam Martin | SVP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,000 | 80,600 | - | - | Incentive Stock Option (Right to Buy) | |
| Editas Medicine Inc | Akshay K. Vaishnaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Andrew J. Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Emma Reeve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | David T. Scadden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Elliott M. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Neuronetics Inc | Glenn P. Muir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 189,647 (1%) | 0% | - | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 139,946 (0%) | 0% | - | Common Stock | |
| Neuronetics Inc | Megan Rosengarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 110,890 (0%) | 0% | - | Common Stock | |
| Payoneer Global Inc | Pamela H. Patsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 24,793 | 180,366 | - | 0 | Common Stock | |
| Payoneer Global Inc | Rich Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 24,793 | 175,339 | - | 0 | Common Stock | |
| Payoneer Global Inc | Sharda Caro del Castillo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 24,793 | 81,887 | - | 0 | Common Stock | |
| Payoneer Global Inc | Amir Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 24,793 | 26,773 | - | 0 | Common Stock | |
| Payoneer Global Inc | Avi Zeevi | Director | 30 May 2024 | 24,793 | 452,377 | - | 0 | Common Stock | ||
| Payoneer Global Inc | Susanna Morgan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 24,793 | 97,082 | - | 0 | Common Stock | |
| First Merchants Corp | Patrick J. Fehring | Director | 30 May 2024 | 23,936 | 122,706 (0%) | 0% | 32.5 | 778,159 | Common | |
| Intel | Patrick P. Gelsinger | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.28 per share. | 30 May 2024 | 23,906 | 34,999 (0%) | 0% | 30.3 | 723,874 | Common Stock |
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,541 | 47,789 | - | 0 | Class A Common Stock | |
| Bakkt Holdings Inc (Class A) | Karen Alexander | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,541 | 39,355 | - | 0 | Class A Common Stock | |
| Industrial Logistics Properties Trust | Bruce M. Gans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,316 | 60,816 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Industrial Logistics Properties Trust | Adam D. Portnoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,316 | 114,852 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Industrial Logistics Properties Trust | Joseph L. Morea | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,316 | 63,316 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Industrial Logistics Properties Trust | Lisa Harris Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,316 | 93,730 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Industrial Logistics Properties Trust | Matthew P. Jordan | Director | 30 May 2024 | 23,316 | 105,028 (0%) | 0% | - | Common Shares of Beneficial Interest | ||
| Industrial Logistics Properties Trust | Kevin C. Phelan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,316 | 58,103 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Industrial Logistics Properties Trust | June S. Youngs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 23,316 | 46,816 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Dream Finders Homes Inc (Class A) | Patrick O. Zalupski | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 30 May 2024 | 23,180 | 1,244,362 | - | 28.2 | 652,749 | Class A common stock, par value $0.01 per share |
| StepStone Grp Inc (Class A) | David F. Hoffmeister | Director | Purchase of securities on an exchange or from another person at price $ 44.29 per share. | 30 May 2024 | 22,500 | 45,853 | - | 44.3 | 996,525 | Class A Common Stock |
| CompoSecure Inc (Class A) | Mitchell L. Hollin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 22,491 | 43,320 | - | 0 | Class A Common Stock | |
| CompoSecure Inc (Class A) | Brian F. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 22,491 | 94,377 | - | 0 | Class A Common Stock | |
| CompoSecure Inc (Class A) | Niloofar Razi Howe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 22,491 | 115,728 | - | 0 | Class A Common Stock | |
| CompoSecure Inc (Class A) | Michele Logan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 22,491 | 43,320 | - | 0 | Class A Common Stock | |
| CompoSecure Inc (Class A) | Jane J. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 22,491 | 94,377 | - | 0 | Class A Common Stock | |
| CompoSecure Inc (Class A) | Paul S. Galant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 22,491 | 89,380 | - | 0 | Class A Common Stock | |
| Intel | April Miller Boise | EVP and Chief Legal Officer | 30 May 2024 | 22,426 | 43,153 (0%) | 0% | - | Common Stock | ||
| Intel | April Miller Boise | EVP and Chief Legal Officer | 30 May 2024 | 22,426 | 44,860 | - | - | Restricted Stock Units | ||
| Universal Corp | George C. Freeman | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 22,140 | 339,814 (1%) | 0% | 0 | Common Stock | |
| Universal Corp | George C. Freeman | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 21,829 | 361,643 (1%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Kevin R. Rhodes | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 30 May 2024 | 21,033 | 54,188 (0%) | 0% | 11.1 | 232,625 | Common Stock |
| BARK Inc (Class A) | Matt Meeker | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 21,000 | 9,947,436 | - | 0 | Common Stock | |
| Celldex Therapeutics Inc | Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | Sale of securities on an exchange or to another person at price $ 33.73 per share. | 30 May 2024 | 20,853 | 1,860 (0%) | 0% | 33.7 | 703,334 | Common Stock |
| Intel | Christoph Schell | EVP; Chief Cml Ofcr; SMG | 30 May 2024 | 20,681 | 61,159 (0%) | 0% | 30.3 | 626,221 | Common Stock | |
| Evolv Tech Holdings Inc (Class A) | David Mounts Gonzales | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 20,544 | 70,544 | - | 0 | Class A Common Stock | |
| Evolv Tech Holdings Inc (Class A) | David Mounts Gonzales | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 20,544 | 0 | - | - | Restricted Stock Units | |
| Clarus Corp | Michael A. Henning | Director | 30 May 2024 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | ||
| Clarus Corp | Nicholas Sokolow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Clarus Corp | Roger L. Werner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Clarus Corp | Donald House | Director | 30 May 2024 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | ||
| Clarus Corp | Susan Ottmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Credo Tech Grp Holding Ltd | Daniel Fleming | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.28 per share. | 30 May 2024 | 20,000 | 724,174 | - | 0.3 | 5,500 | Ordinary Shares |
| Credo Tech Grp Holding Ltd | Daniel Fleming | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 20,000 | 48,800 | - | - | Employee Stock Option (Right to Buy) | |
| Credo Tech Grp Holding Ltd | Daniel Fleming | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.15 per share. | 30 May 2024 | 20,000 | 704,174 | - | 25.2 | 503,052 | Ordinary Shares |
| Expensify Inc (Class A) | Timothy L. Christen | Director | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 30 May 2024 | 19,162 | 122,604 | - | 1.6 | 30,851 | Class A Common Stock |
| Booz Allen Hamilton Holding Corp (Class A) | Susan L. Penfield | EVP & Chief Technology Officer | 30 May 2024 | 18,522 | 33,788 (0%) | 0% | 153.7 | 2,847,387 | Class A Common Stock | |
| Intel | David A. Zinsner | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.28 per share. | 30 May 2024 | 18,347 | 149,281 (0%) | 0% | 30.3 | 555,547 | Common Stock |
| Intel | Michelle Johnston Holthaus | EVP & GM, CCG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.28 per share. | 30 May 2024 | 18,179 | 288,411 (0%) | 0% | 30.3 | 550,460 | Common Stock |
| Repay Holdings Corp (Class A) | Richard E. Thornburgh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 17,525 | 101,956 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 17,525 | 146,656 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | William I. Jacobs | Director | 30 May 2024 | 17,525 | 80,856 (0%) | 0% | 0 | Class A Common Stock | ||
| Repay Holdings Corp (Class A) | Robert Hartheimer | Director | 30 May 2024 | 17,525 | 80,856 (0%) | 0% | 0 | Class A Common Stock | ||
| Repay Holdings Corp (Class A) | Maryann B. Goebel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 17,525 | 80,856 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Emnet Rios | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 17,525 | 63,103 (0%) | 0% | 0 | Class A Common Stock | |
| TTEC Holdings Inc | Francois Bourret | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 17,426 | 17,426 | - | - | Restricted Stock Units | |
| BARK Inc (Class A) | Zahir Ibrahim | Chief Financial Officer | 30 May 2024 | 16,500 | 1,342,996 | - | 0 | Common Stock | ||
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 30 May 2024 | 16,490 | 6,972,027 (10%) | 0% | 103.0 | 1,698,800 | Common Stock | |
| Best Buy | Richard M. Schulze | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 86.50 per share. | 30 May 2024 | 16,254 | 16,873,849 (6%) | 0% | 86.5 | 1,405,925 | Common Stock |
| Vir biotech Inc | Elliott Sigal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | George A. Scangos | Director | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | ||
| Vir biotech Inc | Robert Taylor Nelsen | Director | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | ||
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Vicki L. Sato | Director | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | ||
| Vir biotech Inc | Saira Ramasastry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Jeffrey S. Hatfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Janet Napolitano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Ranpak Holdings Corp (Class A) | Michael A. Jones | Director | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 30 May 2024 | 15,625 | 214,859 (0%) | 0% | 6.4 | 100,156 | Class A common stock |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.17 per share. | 30 May 2024 | 15,207 | 156,855 | - | 21.2 | 321,973 | Class A Common Stock |
| Smith-Midland Corp | Ashley B. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 15,077 | 210,703 | - | 0 | Common Stock | |
| Koss Corp | Michael J. Koss | Director, President and CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 May 2024 | 15,000 | 12,000 (0%) | 0% | 0 | Common Stock | |
| Redwood Trust Inc | Brooke E. Carillo | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 30 May 2024 | 15,000 | 56,772 (0%) | 0% | 6.2 | 93,720 | Common Stock |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 14,766 | 29,532 | - | - | Performance Share Units (2023) | |
| Keurig Dr Pepper | Angela A. Stephens | Senior VP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 14,750 | 14,750 | - | - | Restricted Stock Unit | |
| Netgear Inc | Laura J. Durr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 14,619 | 47,073 (0%) | 0% | 0 | Common Stock | |
| Netgear Inc | Thomas H. Waechter | Director | 30 May 2024 | 14,619 | 67,818 (0%) | 0% | 0 | Common Stock | ||
| Netgear Inc | Janice M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 14,619 | 61,290 (0%) | 0% | 0 | Common Stock | |
| Netgear Inc | Bradley L. Maiorino | Director | 30 May 2024 | 14,619 | 62,658 (0%) | 0% | 0 | Common Stock | ||
| Netgear Inc | Sarah S. Butterfass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 14,619 | 46,370 (0%) | 0% | 0 | Common Stock | |
| Netgear Inc | Shravan K. Goli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 14,619 | 43,313 | - | 0 | Employee Stock Option (Right to Buy) | |
| Hayward Holdings Inc | Stephen J. Felice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 14,286 | 317,057 | - | 0 | Common Stock | |
| Motorola | Gregory Q. Brown | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 14,163 | 31,377 (0%) | 0% | 0 | Motorola Solutions, Inc. - Common Stock | |
| Motorola | Gregory Q. Brown | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 14,162 | 32,475 (0%) | 0% | 0 | Motorola Solutions, Inc. - Common Stock | |
| Cross Country Healthcares Inc - Registered Shares | Marc Krug | Group President, Delivery | Sale of securities on an exchange or to another person at price $ 14.82 per share. | 30 May 2024 | 13,657 | 36,020 (0%) | 0% | 14.8 | 202,397 | Common Stock |
| Bandwidth Inc (Class A) | Daryl E. Raiford | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 30 May 2024 | 13,410 | 68,076 (0%) | 0% | 20.0 | 268,349 | Class A Common Stock |
| Macerich Co. | Steven R. Hash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,317 | 125,328 (0%) | 0% | 0 | Common Stock | |
| CRISPR Therapeutics AG | Maria Fardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Sandesh Mahatme | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | John T. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Douglas A. Treco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | H. Edward Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to buy) | |
| CRISPR Therapeutics AG | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to buy) | |
| Lantheus Holdings Inc | Daniel M. Niedzwiecki | See Remarks | Sale of securities on an exchange or to another person at price $ 79.86 per share. | 30 May 2024 | 12,873 | 80,244 (0%) | 0% | 79.9 | 1,028,038 | Common Stock |
| Allison Transmission Holdings Inc | Rafael Basso | VP, Operations | 30 May 2024 | 12,624 | 4,624 (0%) | 0% | 74.5 | 940,236 | Common Stock | |
| First Merchants Corp | Patrick J. Fehring | Director | 30 May 2024 | 12,554 | 0 | - | - | Non-Employee Director Stock Option (right to buy) | ||
| First Merchants Corp | Patrick J. Fehring | Director | 30 May 2024 | 12,554 | 146,642 (0%) | 0% | 21.8 | 273,552 | Common Stock | |
| CuriosityStream Inc - Ordinary Shares- Class A | Clinton Larry Stinchcomb | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 30 May 2024 | 12,000 | 298,564 | - | 1.0 | 12,480 | Common Stock |
| Insperity Inc | Paul J. Sarvadi | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 95.39 per share. | 30 May 2024 | 11,883 | 525,552 (1%) | 0% | 95.4 | 1,133,519 | Common Stock |
| EverCommerce Inc | Lisa Storey | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 9.66 per share. | 30 May 2024 | 11,233 | 159,263 | - | 9.7 | 108,511 | Common Stock |
| Allogene Therapeutics Inc | Franz Bernard Humer | Director | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 30 May 2024 | 11,200 | 255,253 (0%) | 0% | 2.3 | 26,181 | Common Stock |
| Quest Resource Holding Corp | David P. Sweitzer | EVP and COO | 30 May 2024 | 11,185 | 16,226 (0%) | 0% | 9.0 | 101,194 | Common Stock | |
| Intel | April Miller Boise | EVP and Chief Legal Officer | 30 May 2024 | 11,119 | 32,034 (0%) | 0% | 30.3 | 336,683 | Common Stock | |
| Dream Finders Homes Inc (Class A) | Patrick O. Zalupski | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.35 per share. | 30 May 2024 | 10,984 | 1,267,542 | - | 28.3 | 311,396 | Class A common stock, par value $0.01 per share |
| Tenet Healthcare Corp | Christopher S. Lynch | Director | Sale of securities on an exchange or to another person at price $ 133.83 per share. | 30 May 2024 | 10,861 | 14,759 (0%) | 0% | 133.8 | 1,453,528 | Common Stock |
| Celldex Therapeutics Inc | Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 10,750 | 0 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc | Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 30 May 2024 | 10,750 | 12,610 (0%) | 0% | 2.8 | 29,885 | Common Stock |
| TJX | Kenneth Canestrari | SEVP - Group President | Sale of securities on an exchange or to another person at price $ 104.01 per share. | 30 May 2024 | 10,744 | 100,149 (0%) | 0% | 104.0 | 1,117,459 | Common Stock |
| ICU Medical Inc | Christian Voigtlander | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 103.85 per share. | 30 May 2024 | 10,507 | 2,032 (0%) | 0% | 103.9 | 1,091,156 | Common Stock |
| Quest Resource Holding Corp | David P. Sweitzer | EVP and COO | 30 May 2024 | 10,500 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Quest Resource Holding Corp | David P. Sweitzer | EVP and COO | 30 May 2024 | 10,500 | 27,411 (0%) | 0% | 2.6 | 27,510 | Common Stock | |
| Universal Corp | Airton L. Hentschke | Senior VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,500 | 107,603 (0%) | 0% | 0 | Common Stock | |
| First Merchants Corp | Patrick J. Fehring | Director | 30 May 2024 | 10,383 | 0 | - | - | Non-Employee Director Stock Option (right to buy) | ||
| First Merchants Corp | Patrick J. Fehring | Director | 30 May 2024 | 10,383 | 134,088 (0%) | 0% | 18.0 | 186,998 | Common Stock | |
| Universal Corp | Airton L. Hentschke | Senior VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,358 | 117,961 (0%) | 0% | 0 | Common Stock | |
| Cirrus Logic Inc | David J. Tupman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 10,346 | 5,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cirrus Logic Inc | David J. Tupman | Director | Sale of securities on an exchange or to another person at price $ 114.52 per share. | 30 May 2024 | 10,346 | 21,719 (0%) | 0% | 114.5 | 1,184,824 | Common Stock |
| Cirrus Logic Inc | David J. Tupman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.38 per share. | 30 May 2024 | 10,346 | 32,065 (0%) | 0% | 33.4 | 345,349 | Common Stock |
| Laureate Education Inc | Kenneth W. Freeman | Director | 30 May 2024 | 10,157 | 96,682 | - | 0 | Common Stock | ||
| Celldex Therapeutics Inc | Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 30 May 2024 | 10,103 | 22,713 (0%) | 0% | 9.0 | 91,094 | Common Stock |
| Celldex Therapeutics Inc | Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 10,103 | 0 | - | - | Incentive Stock Option (Right to Buy) | |
| Skyline Champion Corp | Joseph A. Kimmell | EVP, Operations | Sale of securities on an exchange or to another person at price $ 70.12 per share. | 30 May 2024 | 10,042 | 47,262 (0%) | 0% | 70.1 | 704,145 | Common Stock |
| Dicks Sporting Goods Inc | Vladimir Rak | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 10,011 | 0 | - | - | Stock Option (Right to Buy) | |
| Dicks Sporting Goods Inc | Vladimir Rak | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 220.87 per share. | 30 May 2024 | 10,011 | 24,287 (0%) | 0% | 220.9 | 2,211,143 | Common Stock, par value $0.01 per share |
| Dicks Sporting Goods Inc | Vladimir Rak | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.71 per share. | 30 May 2024 | 10,011 | 34,298 (0%) | 0% | 21.7 | 217,339 | Common Stock, par value $0.01 per share |
| Leggett & Platt Inc | Ryan Michael Kleiboeker | EVP-Chief Strategic Plan. Off. | Purchase of securities on an exchange or from another person at price $ 10.95 per share. | 30 May 2024 | 10,000 | 52,109 (0%) | 0% | 10.9 | 109,499 | Common Stock |
| Keros Therapeutics Inc | Carl L. Gordon | Director | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Ran Nussbaum | Director, Ten Percent Owner | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Nima Farzan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| PennantPark Floating Rate Cap Ltd | Richard T. Allorto | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 11.30 per share. | 30 May 2024 | 10,000 | 10,000 (0%) | 0% | 11.3 | 113,000 | Common Stock |
| Xponential Fitness Inc (Class A) | Brenda I. Morris | Director | 30 May 2024 | 9,888 | 35,882 | - | 0 | Class A Common Stock | ||
| Xponential Fitness Inc (Class A) | Chelsea A. Grayson | Director | 30 May 2024 | 9,888 | 22,774 | - | 0 | Class A Common Stock | ||
| Xponential Fitness Inc (Class A) | Jeffrey D. Lawrence | Director | 30 May 2024 | 9,888 | 10,369 | - | 0 | Class A Common Stock | ||
| Xponential Fitness Inc (Class A) | Mark Grabowski | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,888 | 27,901 | - | 0 | Class A Common Stock | |
| Xponential Fitness Inc (Class A) | Jair Clarke | Director | 30 May 2024 | 9,888 | 16,606 | - | 0 | Class A Common Stock | ||
| Universal Corp | George C. Freeman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.30 per share. | 30 May 2024 | 9,845 | 351,798 (1%) | 0% | 47.3 | 465,669 | Common Stock |
| Tenet Healthcare Corp | J. Robert Kerrey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 9,500 | 36,903 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp | J. Robert Kerrey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2024 | 9,500 | 9,500 (0%) | 0% | 0 | Common Stock | |
| Macerich Co. | Enrique Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,103 | 36,249 (0%) | 0% | 0 | Common Stock | |
| Macerich Co. | Daniel J. Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,103 | 71,106 (0%) | 0% | 0 | Common Stock | |
| Macerich Co. | Andrea M. Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,103 | 83,479 (0%) | 0% | 0 | Common Stock | |
| Macerich Co. | Marianne Lowenthal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,103 | 34,528 (0%) | 0% | 0 | Common Stock | |
| Hayward Holdings Inc | Lori A. Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,060 | 39,337 | - | 0 | Common Stock | |
| Hayward Holdings Inc | Arthur L Soucy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,060 | 31,662 | - | 0 | Common Stock | |
| Hayward Holdings Inc | Diane S. Dayhoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,060 | 37,337 | - | 0 | Common Stock | |
| Hayward Holdings Inc | Edward D. Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 9,060 | 29,985 | - | 0 | Common Stock | |
| 22nd Century Grp Inc | Lawrence D. Firestone | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 30 May 2024 | 9,000 | 15,250 (0%) | 0% | 1.1 | 9,829 | Common Stock |
| Dicks Sporting Goods Inc | Vladimir Rak | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 221.60 per share. | 30 May 2024 | 8,981 | 24,287 (0%) | 0% | 221.6 | 1,990,190 | Common Stock, par value $0.01 per share |
| Laureate Education Inc | Andrew B. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,939 | 49,709 | - | 0 | Common Stock | |
| Tenet Healthcare Corp | J. Robert Kerrey | Director | Sale of securities on an exchange or to another person at price $ 133.30 per share. | 30 May 2024 | 8,699 | 801 (0%) | 0% | 133.3 | 1,159,577 | Common Stock |
| Edwards Lifesciences | Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 87.68 per share. | 30 May 2024 | 8,617 | 68,217 (0%) | 0% | 87.7 | 755,539 | Common Stock |
| Allegro Microsystems Inc | Richard R. Lury | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 30 May 2024 | 8,500 | 23,001 | - | 30 | 255,000 | Common Stock |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 30 May 2024 | 8,500 | 47,671 (0%) | 0% | 9.0 | 76,640 | Common Stock |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 8,500 | 7,500 | - | - | Incentive Stock Option (Right to Buy) | |
| Quest Resource Holding Corp | David P. Sweitzer | EVP and COO | 30 May 2024 | 8,400 | 16,911 (0%) | 0% | 2.5 | 20,580 | Common Stock | |
| Quest Resource Holding Corp | David P. Sweitzer | EVP and COO | 30 May 2024 | 8,400 | 2,100 | - | - | Employee Stock Option (Right to Buy) | ||
| Upstart Holdings Inc | Sukhinder Singh Cassidy | Director | 30 May 2024 | 8,278 | 28,270 | - | 0 | Common Stock | ||
| Upstart Holdings Inc | Kerry Whorton Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,278 | 8,278 | - | 0 | Common Stock | |
| Upstart Holdings Inc | Mary Hentges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,278 | 25,733 | - | 0 | Common Stock | |
| Upstart Holdings Inc | Ciaran O’Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,278 | 26,761 | - | 0 | Common Stock | |
| Callaway Golf Co | Anthony S. Thornley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | |
| Callaway Golf Co | John F. Lundgren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Erik J. Anderson | Director | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | ||
| Callaway Golf Co | Russell L. Fleischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Linda B. Segre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Adebayo O. Ogunlesi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Laura Jean Flanagan | Director | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | ||
| Callaway Golf Co | Varsha R. Rao | Director | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | ||
| Callaway Golf Co | Bavan M. Holloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Scott M. Marimow | Director | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | ||
| Callaway Golf Co | C. Matthew Turney | Director | 30 May 2024 | 8,096 | 8,096 | - | - | Restricted Stock Units | ||
| Vir biotech Inc | Elliott Sigal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 23,806 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | George A. Scangos | Director | 30 May 2024 | 8,000 | 120,989 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | Robert Taylor Nelsen | Director | 30 May 2024 | 8,000 | 584,148 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 46,683 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Vicki L. Sato | Director | 30 May 2024 | 8,000 | 1,323,351 (1%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | Saira Ramasastry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 18,619 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Jeffrey S. Hatfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 23,806 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Janet Napolitano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 23,806 (0%) | 0% | 0 | Common Stock | |
| Reddit Inc (Class A) | Michelle Marie Reynolds | Chief Accounting Officer | 30 May 2024 | 8,000 | 66,238 | - | 60 | 480,000 | Class A Common Stock | |
| Tenet Healthcare Corp | J. Robert Kerrey | Director | Sale of securities on an exchange or to another person at price $ 134.65 per share. | 30 May 2024 | 7,964 | 46,403 (0%) | 0% | 134.7 | 1,072,353 | Common Stock |
| Laureate Education Inc | Ian K. Snow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,957 | 7,957 | - | 0 | Common Stock | |
| Laureate Education Inc | George Munoz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,957 | 119,986 | - | 0 | Common Stock | |
| Laureate Education Inc | Judith Rodin | Director | 30 May 2024 | 7,957 | 89,497 | - | 0 | Common Stock | ||
| Laureate Education Inc | Pedro del Corro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,957 | 54,686 | - | 0 | Common Stock | |
| Laureate Education Inc | Aristides de Macedo Murgel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,957 | 14,144 | - | 0 | Common Stock | |
| Laureate Education Inc | Barbara Mair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,957 | 23,940 | - | 0 | Common Stock | |
| Biocryst Pharma Inc | Alan G. Levin | Director | Purchase of securities on an exchange or from another person at price $ 6.36 per share. | 30 May 2024 | 7,861 | 44,951 (0%) | 0% | 6.4 | 49,996 | Common Stock |
| Xponential Fitness Inc (Class A) | Brenda I. Morris | Director | 30 May 2024 | 7,855 | 43,737 | - | 0 | Class A Common Stock | ||
| Quest Resource Holding Corp | David P. Sweitzer | EVP and COO | 30 May 2024 | 7,715 | 8,511 (0%) | 0% | 9.0 | 69,551 | Common Stock | |
| Cibus Inc (Class A) | Jean-Pierre Jules Lehmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,712 | 7,712 | - | - | Stock Option (Right-to-Buy) | |
| Cibus Inc (Class A) | Keith Allen Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,712 | 7,712 | - | - | Stock Option (Right-to-Buy) | |
| Cibus Inc (Class A) | Mark Terrence Finn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,712 | 7,712 | - | - | Stock Option (Right-to-Buy) | |
| Backblaze Inc (Class A) | Frank Patchel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.45 per share. | 30 May 2024 | 7,679 | 165,302 | - | 6.5 | 49,530 | Class A Common Stock |
| Community West Bancshares. | Shannon R Livingston | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 16.49 per share. | 30 May 2024 | 7,581 | 14,570 (0%) | 0% | 16.5 | 125,011 | CWBC - Common Stock |
| Westwood Holdings Grp Inc | Randy A. Bowman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,547 | 26,062 (0%) | 0% | 0 | common stock | |
| BARK Inc (Class A) | Allison Koehler | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,500 | 404,798 | - | 0 | Common Stock | |
| Powell Industries Inc | Thomas W. Powell | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 206.21 per share. | 30 May 2024 | 7,374 | 1,675,040 (14%) | 0% | 206.2 | 1,520,629 | Common Stock |
| Roblox Corp (Class A) | Jason Kilar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,334 | 19,805 | - | 0 | Restricted Stock Unit | |
| Roblox Corp (Class A) | Gina Mastantuono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,334 | 21,706 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | Andrea Wong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,334 | 33,653 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | Gregory Baszucki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,334 | 16,554 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | Christopher Carvalho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,334 | 982,412 | - | 0 | Class A Common Stock | |
| Huntington Bancshares | Helga Houston | Senior Exec. V. P. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.66 per share. | 30 May 2024 | 7,323 | 641,581 (0%) | 0% | 13.7 | 99,996 | Common Stock |
| Huntington Bancshares | Helga Houston | Senior Exec. V. P. | Sale of securities on an exchange or to another person at price $ 13.64 per share. | 30 May 2024 | 7,278 | 648,904 (0%) | 0% | 13.6 | 99,238 | Common Stock |
| Coinbase Global Inc (Class A) | Jennifer N. Jones | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 7,200 | 900 | - | - | Employee Stock Option (right to buy) | |
| Coinbase Global Inc (Class A) | Jennifer N. Jones | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.46 per share. | 30 May 2024 | 7,200 | 16,335 | - | 23.5 | 168,912 | Class A Common Stock |
| Exponent Inc | Paul R. Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.05 per share. | 30 May 2024 | 7,000 | 86,236 (0%) | 0% | 29.1 | 203,350 | Common Stock |
| Exponent Inc | Paul R. Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 7,000 | 35,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Exponent Inc | Paul R. Johnston | Director | Sale of securities on an exchange or to another person at price $ 93.95 per share. | 30 May 2024 | 7,000 | 79,236 (0%) | 0% | 93.9 | 657,641 | Common Stock |
| DoorDash | Ravi Inukonda | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 110.47 per share. | 30 May 2024 | 7,000 | 441,851 | - | 110.5 | 773,290 | Class A Common Stock |
| Universal Corp | Johan C. Kroner | Senior VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,960 | 48,301 (0%) | 0% | 0 | Common Stock | |
| Universal Corp | Johan C. Kroner | Senior VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,863 | 55,164 (0%) | 0% | 0 | Common Stock | |
| IPG Photonics Corp | Michael C. Child | Director | 30 May 2024 | 6,500 | 0 | - | - | Director Stock Option (right to buy) | ||
| IPG Photonics Corp | Michael C. Child | Director | 30 May 2024 | 6,500 | 65,603 (0%) | 0% | 63.4 | 412,100 | Common Stock | |
| Smith-Midland Corp | Matthew I. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,485 | 12,363 | - | 0 | Common Stock | |
| Tenet Healthcare Corp | J. Robert Kerrey | Director | Sale of securities on an exchange or to another person at price $ 133.20 per share. | 30 May 2024 | 6,358 | 54,367 (0%) | 0% | 133.2 | 846,886 | Common Stock |
| Artivion Inc | Daniel J. Bevevino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 143,736 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Jeffrey H. Burbank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 47,471 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Jon W. Salveson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 123,515 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Thomas F. Ackerman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 143,571 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | James W. Bullock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 62,322 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marna P. Borgstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 42,763 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Anthony B. Semedo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 43,868 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Elizabeth A. Hoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,289 | 25,064 (0%) | 0% | 0 | Common Stock | |
| Kite Realty Grp Trust | Peter L. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 70,250 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | Victor J. Coleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 88,313 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | Christie B. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 66,225 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | Barton R. Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 80,169 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | David R. O’Reilly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 63,313 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | Steven P. Grimes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 769,547 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | Bonnie S. Biumi | Director | 30 May 2024 | 6,233 | 68,069 (0%) | 0% | 0 | Common Shares | ||
| Kite Realty Grp Trust | Charles H. Wurtzebach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 60,171 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | Derrick Burks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 25,570 (0%) | 0% | 0 | Common Shares | |
| Kite Realty Grp Trust | Caroline L Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,233 | 37,138 (0%) | 0% | 0 | Common Shares | |
| Cibus Inc (Class A) | Jean-Pierre Jules Lehmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,072 | 77,857 (0%) | 0% | 0 | Class A Common Stock | |
| Cibus Inc (Class A) | Gerhard Prante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,072 | 77,857 (0%) | 0% | 0 | Class A Common Stock | |
| Community West Bancshares. | Jeffrey Michael Martin | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 16.49 per share. | 30 May 2024 | 6,065 | 18,106 (0%) | 0% | 16.5 | 100,012 | CWBC - Common Stock |
| SmartKem Inc | Klaas de Boer | Director | 30 May 2024 | 5,715 | 11,430 | - | - | Common Stock | ||
| Blink Charging Co | Brendan Sean Jones | Director, President and CEO | 30 May 2024 | 5,688 | 246,219 (0%) | 0% | 3.2 | 18,031 | Common Stock, par value $0.001 per share | |
| Hudson Pacific Properties Inc | Arthur Suazo | EVP, Leasing | Purchase of securities on an exchange or from another person at price $ 4.56 per share. | 30 May 2024 | 5,600 | 92,702 (0%) | 0% | 4.6 | 25,536 | Common Stock, par value $0.01 |
| Appian Corp (Class A) | Albert G.W. Biddle | Director | Purchase of securities on an exchange or from another person at price $ 27.98 per share. | 30 May 2024 | 5,500 | 27,464 (0%) | 0% | 28.0 | 153,890 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.